Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuo Toda

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Pancreas|February 10, 2025
Impact of Statin Use on Survival in Patients With Unresectable Pancreatic cancer Receiving Gemcitabine Plus Nab-Paclitaxel: A Multicenter Retrospective StudyKei Saito, Yousuke Nakai, Takashi Sasaki, et al.
Journal of Gastroenterology|January 29, 2013
Management of dysfunctional covered self-expandable metallic stents in patients with malignant distal biliary obstructionOsamu Togawa, Hiroyuki Isayama, Takeshi Tsujino, et al.
Journal of Gastroenterology and Hepatology|December 19, 2007
Efficacy and safety of low-pressured and short-time dilation in endoscopic papillary balloon dilation for bile duct stone removalTakeshi Tsujino, Takao Kawabe, Hiroyuki Isayama, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 20, 2007
Endoscopic papillary balloon dilation for bile duct stone: immediate and long-term outcomes in 1000 patientsTakeshi Tsujino, Takao Kawabe, Yutaka Komatsu, et al.
Journal of Gastroenterology|October 24, 2012
The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trialTakeshi Tsujino, Hiroyuki Isayama, Yousuke Nakai, et al.
Investigational New Drugs|October 7, 2010
Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabineTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|July 5, 2014
Clinical outcomes of secondary gastroduodenal self-expandable metallic stent placement by stent-in-stent technique for malignant gastric outlet obstructionTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Pancreas|November 14, 2012
High alcohol consumption increases the risk of pancreatic stone formation and pancreatic atrophy in autoimmune pancreatitisKenji Hirano, Minoru Tada, Hiroyuki Isayama, et al.
Pancreas|January 18, 2012
Long-term prognosis of autoimmune pancreatitis in terms of glucose toleranceKenji Hirano, Akihiro Isogawa, Minoru Tada, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 4, 2011
Lower incidence of biliary carcinoma in patients with primary sclerosing cholangitis and high serum levels of immunoglobulin EKenji Hirano, Minoru Tada, Suguru Mizuno, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Pancreas|February 10, 2025
Impact of Statin Use on Survival in Patients With Unresectable Pancreatic cancer Receiving Gemcitabine Plus Nab-Paclitaxel: A Multicenter Retrospective StudyKei Saito, Yousuke Nakai, Takashi Sasaki, et al.
Journal of Gastroenterology|January 29, 2013
Management of dysfunctional covered self-expandable metallic stents in patients with malignant distal biliary obstructionOsamu Togawa, Hiroyuki Isayama, Takeshi Tsujino, et al.
Journal of Gastroenterology and Hepatology|December 19, 2007
Efficacy and safety of low-pressured and short-time dilation in endoscopic papillary balloon dilation for bile duct stone removalTakeshi Tsujino, Takao Kawabe, Hiroyuki Isayama, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 20, 2007
Endoscopic papillary balloon dilation for bile duct stone: immediate and long-term outcomes in 1000 patientsTakeshi Tsujino, Takao Kawabe, Yutaka Komatsu, et al.
Journal of Gastroenterology|October 24, 2012
The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trialTakeshi Tsujino, Hiroyuki Isayama, Yousuke Nakai, et al.
Investigational New Drugs|October 7, 2010
Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabineTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|July 5, 2014
Clinical outcomes of secondary gastroduodenal self-expandable metallic stent placement by stent-in-stent technique for malignant gastric outlet obstructionTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Pancreas|November 14, 2012
High alcohol consumption increases the risk of pancreatic stone formation and pancreatic atrophy in autoimmune pancreatitisKenji Hirano, Minoru Tada, Hiroyuki Isayama, et al.
Pancreas|January 18, 2012
Long-term prognosis of autoimmune pancreatitis in terms of glucose toleranceKenji Hirano, Akihiro Isogawa, Minoru Tada, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 4, 2011
Lower incidence of biliary carcinoma in patients with primary sclerosing cholangitis and high serum levels of immunoglobulin EKenji Hirano, Minoru Tada, Suguru Mizuno, et al.
Pageof 9